Menu Close

Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010

Citation

Ewing, Alexander C.; Davis, Nicole L.; Kayira, Dumbani; Hosseinipour, Mina C.; van der Horst, Charles M.; Jamieson, Denise J.; Kourtis, Athena P., and the BAN Study Team [; Linda S. Adair; and; & Sandra S. Albrecht, Members, et al. (2019). Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010. Emerging Infectious Diseases, 25(1), 103-112. PMCID: PMC6302572

Abstract

Antimicrobial drug resistance is a serious health hazard driven by overuse. Administration of antimicrobial drugs to HIV-exposed, uninfected infants, a population that is growing and at high risk for infection, is poorly studied. We therefore analyzed factors associated with antibacterial drug administration to HIV-exposed, uninfected infants during their first year of life. Our study population was 2,152 HIV-exposed, uninfected infants enrolled in the Breastfeeding, Antiretrovirals and Nutrition study in Lilongwe, Malawi, during 2004-2010. All infants were breastfed through 28 weeks of age. Antibacterial drugs were prescribed frequently (to 80% of infants), and most (67%) of the 5,329 prescriptions were for respiratory indications. Most commonly prescribed were penicillins (43%) and sulfonamides (23%). Factors associated with lower hazard for antibacterial drug prescription included receipt of cotrimoxazole preventive therapy, receipt of antiretroviral drugs, and increased age. Thus, cotrimoxazole preventive therapy may lead to fewer prescriptions for antibacterial drugs for these infants.

URL

http://dx.doi.org/10.3201/eid2501.180782

Reference Type

Journal Article

Year Published

2019

Journal Title

Emerging Infectious Diseases

Author(s)

Ewing, Alexander C.
Davis, Nicole L.
Kayira, Dumbani
Hosseinipour, Mina C.
van der Horst, Charles M.
Jamieson, Denise J.
Kourtis, Athena P., and the BAN Study Team [
Linda S. Adair
and
Sandra S. Albrecht, Members
]

PMCID

PMC6302572